Extracellular matrix pathway emerges as treatment target for pediatric cancer

Published Date: 24 Jul 2025

Researchers at Children's Hospital Los Angeles have discovered a key difference between the two main types of rhabdomyosarcoma—paving the way for more targeted treatments.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

2.

Invest in generics as a lesson from the shortages of chemotherapy.

3.

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

4.

AI model combines clinical and magnetic resonance data to improve prediction of breast cancer recurrence

5.

Ignoring Colonoscopy Advice; Dry Mouth Acupuncture; Inflamed Tongue, Then Cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot